Medical Prognosis Institute/Oncology Venture

Venlighedsvej 1
Hoersholm,  DK-2970

Denmark
http://www.medical-prognosis.com/http://www.oncologyventure.com
  • Booth: 22102

Medical Prognosis Institute (MPI), Oncology Venture (OV) & 2X-Oncology Inc. We match patients and drugs. MPI develops Precision Medicine via our mRNA Drug Response Predictor-DRP™, a unique companion diagnostic tool. OV - a spinout MPI - uses the DRP(TM) to select high likelihood responding patients for its pipeline of 7 focused Phase 2 anti cancer drugs. Three of these drugs are developed in 2X-Oncology Inc. a Precision Medicine company for Woman’s Cancer & spin out of OV.


  •  
  •      
     

  •  
  •